Viscosupplementation with hylan G-F 20 in patients with osteoarthrosis of the knee

Therapeutic Advances in Musculoskeletal Disease

Volumn 2, Issue 3, 2010, Pages 127-132

  Bert, Jack M ^a   Waddell, David D ^b  

^a Summit Orthopedics Ltd Minnesota   (United States)

^b Orthopedics Specialists of Louisiana   (United States)

Author keywords

knee osteoarthritis; postarthroscopy; viscosupplementation

Indexed keywords

EID: 84993767970     PISSN: 1759720X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1759720X10370930     Document Type: Review

References (55)

1. Altman, R. and Moskowitz, R. ( 1998) Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: A randomized clinical trial. Hyalgan Study Group. J Rheumatol 25: 2203-2212.
2. American Academy of Orthopedic Surgeons (2008 ) Treatment of Osteaoarthritis of the Knee (Non-arthroplasty): Complete Guideline, American Academy of Orthopedic Surgeons : Rosemont, IL.
3. Anika Therapeutics ( 2005) Orthovisc (sodium hyaluronate) [product information], Anika Therapeutics: Woburn, MA.
4. Bagga, H., Burkhardt, D., Sambrook, P. and March, L. ( 2006) Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 33: 946-950.
5. Bellamy, N., Campbell, J., Robinson, V., Gee, T., Bourne, R. and Wells, G. ( 2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev, CDOO5321.
6. Belmonte, C., Pozo, M. and Balazs, E. ( 1998) Modulation by hyaluronan and its derivatives (hylans) of sensory nerve activity signaling articular pain, In: Laurent, T. (ed.). Chemistry, Biology and Medical Applications of Hyaluronan and its Derivatives. Proceedings of the Wenner-Gren Foundation International Symposium, Portland Press: London, pp. 205-217.
7. Bin, S., Lee, S., Kim, C., Kim, T. and Lee, D. ( 2008) Results of arthroscopic medial meniscectomy in patients with grade IV osteoarthritis of the medial compartment. Arthroscopy 24: 264-268.
8. Burns, W., Bourne, R., Chesworth, B., MacDonald, S. and Rorabeck, R. ( 2006) Cost effectiveness of revision total knee arthroplasty. Clin Orthop Relat Res 446: 29-33.
9. Caborn, O., Rush, J., Lanzer, W., Parenti, O. and Murray, C. ( 2004) A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol 31: 333-343.
10. Carrabba, M., Paresce, E., Angelini, M., Re, K., Torchiana, E. and Perbellini, A. ( 1995) The safety and efficiency of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 15: 25-31.
11. Centers for Disease Control and Prevention ( 2001 ) Prevalence of disabilities and associated health conditions among adults-United States, 1999. MMWR Morb Mortal Wkly Rep 50: 120-125.
12. Chen, Y., Peng, O., Sun, C., Wang, W., Li, J. and Zhang, W. ( 2002) Clinical study on sodium hyaluronate intra-articular injection in treatment of degenerative osteoarthritis of knee. Zhongguo Xiu Follow up Chong lian Wai Ke Za Zhi 16: 19-20, in Chinese.
13. Chevalier, X. (2009) Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis 19: 1-7.
14. Clarke, S., Lock, V., Duddy, J., Sharif, M., Newman, J.H. and Kirwan, J.R. ( 2005) Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK). Knee 12: 57-62.
15. Dai, G.F., Tang, J.W., Wang, S.J., Liu, Q. and Shi, D.P. ( 2002) Efficacy of intrarticular injection of sodium hyalurnate in post-operative treatment of the knee. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 16: 16-18 (in Chinese).
16. Dougados, M., Nguyen, M., Listrat, V. and Amor, B. ( 1993) High molecular weight sodium hyaluronate (Hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage 1: 97-103.
17. Ferring Pharmaceuticals (2006) Euflexxa [prescribing information], Ferring Pharmaceuticals : Saint-Prex, Switzerland.
18. Evanich, J., Evanich, C., Wright, M. and Rydlewicz, J. ( 2001) Efficacy of intraarticular hyaluronic acid injections in knee osteoarthritis. Clin Orthop Relat Res 390: 173-181.
19. Genzyme Biosurgery (2006) Synvisc (hylan G-F 20) [product information], Genzyme Biosurgery : Cambridge, MA.
20. Gray, R. and Gottlieb, N. ( 1983) Intra-articular corticosteroids. An updated assessment. Clin Orthop Rel Res 177: 235-263.
21. Grecomoro, G., Martorana, D. and Di Marco, C. ( 1987) Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica 5: 137-141.
22. Hempfling, H. ( 2007) Intra-articular hyaluronic acid after knee arthroscopy: a two-year study. Knee Surg Sports Traumatol Arthrosc 15: 537-546.
23. Huang, M.H., Yang, R.C. and Chou, P.H. ( 2007) Preliminary effects of hyaluronic acid on early rehabilitation of patients with isolated anterior cruciate ligament reconstruction. Clin J Sport Med 17: 242-250.
24. Huskin, J., Vandekerckhove, B. and Delince, P. ( 2008) Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy. Knee Surg Sports Traumatol Arthrosc 16: 747-752.
25. Huskisson, E. and Donnelly, S. ( 1999) Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 38: 602-607.
26. Kahan, A., Lieu, P. and Salin, L. ( 2003) Prospective randomized study comparing the medico-economic benefits of hylan G-F 20 vs. conventional treatment in knee osteoarthritis. Joint Bone Spine 70: 276-281.
27. Kemper, F., Gebhardt, D., Meng, T. and Murray, C. ( 2005) Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin 21: 1261-1269.
28. Kirchner, M. and Marshall, D. ( 2006) A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage 14: 154-162.
29. Kolarz, G., Kotz, R. and Hochmayer, W. ( 2003) Long term benefits and repeated treatment cycles of intra-articular sodium hyaluronate in patients with osteoarthritis of the knee. Semin Arthritis Rheum 32: 310-319.
30. Lo, G., LaValley, M., McAlindon, T. and Felson, D. ( 2004) Intra-articular hyaluronic acid in treatment of knee osteoarthritis. A meta-analysis. JAMA 290: 3115-3121.
31. Lussier, A., Cividino, A., McFarlane, C., Olszynski, W., Potashner, W. and de Medicis, R. ( 1996) Viscosupplementation with hylan for the treatment of osteoarthritis: Findings from clinical practice in Canada. J Rheumatol 23: 1579-1585.
32. Marino, A., Waddell, D., Kolomytkin, O., Meek, W., Wolf, R., Sadasivan, K. and Albright, J. ( 2004) Increased intercellular communication through gap junctions may contribute to progression of osteoarthritis. Clin Orthop Relat Res 422: 224-232.
33. Marshall, O., Johnell, O. and Wedel, H. ( 1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312: 1254-1259.
34. Mathies, B. ( 2006) Effects of viscoseal, a synovial fluid substitute on recovery after arthroscopic partial meniscectomy and joint lavage. Knee Surg Sports Traumatol Arthrosc 14: 32-39.
35. Moore, A. and Willoughby, D. ( 1995) Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action. Int J Tissue React 17: 153-156.
36. Neustadt, D. ( 2003) Long-term efficacy and safety of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Clin Exp Rheumatol 21: 307-311.
37. Raman, R., Dutta, A., Day, N., Sharma, H.K., Shaw, C.J. and Johnson, G.V. ( 2008) Efficacy of hylan G-F 20 and sodium hyaluronate in the treatment of osteoarthritis of the knee-a prospective randomized clinical trial. Knee 15: 318-324.
38. Raynaud, J. ( 2005) Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis Cartilage 13: 111-119.
39. Raynaud, J., Torrance, G. and Band, P. ( 2002) A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 1 of 2): Clinical results. Osteoarthritis Cartilage 10: 506-517.
40. Rolf, C.G., Engstrom, B., Ohrvik, J., Valentin, A., Lija, B. and Levin, D.W. ( 2005) A comparative study of the efficacy and safety of hyaluronan viscosupplements and placebo in patients with symptomatic and arthroscopy-verified cartilage pathology. J Clin Res 8: 15-32.
41. Sanofiaventis (2007) Hyalgan [prescribing information], Sanofiaventis US LLC: Bridgewater, NJ.
42. Scale, D., Wobig, M. and Wolpert, W. ( 1994) Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Ther Res 55: 220-232.
43. Scientific Group W.H.O. (2003) The burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser 919, i-ix, 1-218, back cover.
44. Seikagaku (2007) Supartz [product information], Seikagaku: Tokyo.
45. Ulucay, C., Altintas, F., Ugutmen, E. and Beksac, B. ( 2007) The use of arthroscopic debridement and viscosupplementation in knee osteoarthritis. Acta Orthop Traumatol Turc 41: 337-342.
46. Waddell, D. ( 2007) Viscosupplementation with hyaluronans for osteoarthritis of the knee. Drugs Aging 24: 629-642.
47. Waddell, D. and Bricker, D. ( 2006a) Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg 19: 19-27.
48. Waddell, D. and Bricker, D. ( 2006b) Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review. J Surg Orthop Adv 15: 53-59.
49. Waddell, D. and Bricker, D. ( 2007) Total knee replacement delayed with hylan G-F 20 use in patients with grade IV osteoarthritis. J Manag Care Pharm 13: 113-121.
50. Waddell, D., Cefalu, C. and Bricker, D. ( 2003) An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis. Curr Med Res Opin 19: 499-507.
51. Waddell, D., Cefalu, C. and Bricker, D. ( 2005) A second course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12-month patient follow-up. J Knee Surg 18: 6-15.
52. Wang, C., Lin, J., Chang, C., Lin, Y. and Hou, S. ( 2004) Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86A: 538-545.
53. Wobig, M., Beks, P., Dickhut, A., Maier, R. and Vetter, G. ( 1999) Open-label multicenter trial of the safety and efficacy of viscosupplementation with hylan G-F 20 (Synvisc) in primary osteoarthritis of the knee. J Clin Rheumatol 1999; 5: S24-S31.
54. Wobig, M., Dickhut, A., Maier, R. and Veller, G. ( 1998) Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20: 410-423.
55. Zietz, P. and Selesnick, H. ( 2008) The use of hylan G-F 20 after knee arthroscopy in an active patient population with knee osteoarthritis. Arthroscopy 24: 416-422.